The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Tumor necrosis factor and interleukin 1 decrease RXRα, PPARα, PPARγ, LXRα, and the coactivators SRC-1, PGC-1α, and PGC-1β in liver cells
Open accessAbstract
During the acute phase response, cytokines induce marked alterations in lipid metabolism including an increase in serum triglyceride levels and a decrease in hepatic fatty acid oxidation, in bile acid synthesis, and in high-density lipoprotein levels. Here we demonstrate that tumor necrosis factor (TNF) and interleukin 1 (IL-1), but not IL-6, decrease the expression of retinoid X receptor alpha (RXRalpha), peroxisome proliferator-activated receptor alpha (PPARalpha), PPARgamma, liver X receptor alpha (LXRalpha), and coactivators PPARgamma coactivator 1alpha (PGC-1alpha), PGC-1beta, and steroid receptor coactivator 1 (SRC-1) in Hep3B human hepatoma cells. In addition, treatment of mice with TNF and IL-1 also decreased RXRalpha, PPARalpha, PPARgamma, LXRalpha, and PGC-1alpha messenger RNA (mRNA) levels in the liver. These decreases were accompanied by reduced binding of nuclear extracts to RXR, PPAR, and LXR response elements and decreased luciferase activity driven by PPAR and LXR response elements. In addition, the mRNA levels of proteins regulated by PPARalpha (carnitine palmitoyltransferase 1alpha) and LXR (sterol regulatory element binding protein) were decreased in Hep3B cells treated with TNF or IL-1. Finally, using constructs of the LXRalpha promoter or the PGC-1alpha promoter linked to luciferase, we were able to demonstrate that a decrease in transcription contributes to the reduction in mRNA levels of nuclear hormone receptors and coactivators. Thus, our results suggest that decreased expression of nuclear hormone receptors RXRalpha, PPARalpha, PPARgamma, and LXRalpha, as well as coactivators PGC-1alpha, PGC-1beta, and SRC-1 may contribute to the cytokine-induced alterations in hepatic lipid metabolism during the acute phase response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also proinflammatory cytokines interleukin 1β (IL-1b) and tumour necrosis factor α (TNF-a) have been shown to suppress LXR activity36”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [36]
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
Kushner, I. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22124.x · Cited by 1,494
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Self-citationKishimoto, T., Taga, T., & Akira, S. (1994) · Cell · doi:10.1016/0092-8674(94)90333-6 · Cited by 1,318
The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
Kolesnick, R. N. (1994) · Cell · doi:10.1016/0092-8674(94)90147-3 · Cited by 916
Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors
Lee, C., Olson, P., & Evans, R. M. (2003) · Endocrinology · doi:10.1210/en.2003-0288 · Cited by 891
Xu, J., Qiu, Y., DeMayo, F. J., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1998) · Science · doi:10.1126/science.279.5358.1922 · Cited by 680
Martin, G., Schoonjans, K., Lefebvre, A.-M., Staels, B., & Auwerx, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28210 · Cited by 551
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.009 · Cited by 848
Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.009 · Cited by 708
Stienstra, R., Joosten, L. A. B., Koenen, T. B., van Tits, B. L. J. H., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 700
Stienstra, R., Saudale, F., Duval, C., Keshtkar, S., Groener, J. E. M., van Rooijen, N., Staels, B., Kersten, S., & Müller, M. (2010) · Hepatology · doi:10.1002/hep.23337 · Cited by 452
Tosello-Trampont, A.-C., Landes, S. G., Nguyen, V., Novobrantseva, T. I., & Hahn, Y. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417014 · Cited by 415
Lu, Q., Zhu, Y., Deng, C., Liang, Z., Chen, J., Chen, Y., Wang, X., Liu, Y., Tian, Y., & Yang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01756-w · Cited by 391
The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases
Fontecha‐Barriuso, M., Martín‐Sánchez, D., Martinez-Moreno, J. M., Monsalve, M., Ramos, A. M., Sánchez-Niño, M. D., Ruiz‐Ortega, M., Ortíz, A., & Sanz, A. B. (2020) · Biomolecules · doi:10.3390/biom10020347 · Cited by 303
Inflammation stimulates the expression of PCSK9
Feingold, K. R., Moser, A. H., Shigenaga, J. K., Patzek, S. M., & Grünfeld, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.023 · Cited by 228
Self-citationHepatic metabolism of retinoids and disease associations
Shirakami, Y., Lee, S.-A., Clugston, R. D., & Blaner, W. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.023 · Cited by 203
Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation
Ghosh, S., Massey, H. D., Krieg, R. J., Fazelbhoy, Z., Ghosh, S., Sica, D. A., Fakhry, I., & Gehr, T. W. B. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90732.2008 · Cited by 141
Frambach, S. J. C. M., de Haas, R., Smeitink, J. A. M., Rongen, G. A. P. J. M., Rüssel, F. G. M., & Schirris, T. J. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017897 · Cited by 146
Feingold, K. R., Grünfeld, C., Heuer, J. G., Gupta, A., Cramer, M. S., Zhang, T., Shigenaga, J. K., Patzek, S. M., Chan, Z. W., Moser, A. H., et al. (2012) · Endocrinology · doi:10.1210/en.2011-1496 · Cited by 130
Self-citationAho, V., Ollila, H. M., Kronholm, E., Bondia-Pons, I., Soininen, P., Kangas, A. J., Hilvo, M., Seppälä, I., Kettunen, J., Oikonen, M., et al. (2016) · Scientific Reports · doi:10.1038/srep24828 · Cited by 126
LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney
Feingold, K. R., Wang, Y., Moser, A. H., Shigenaga, J. K., & Grünfeld, C. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800233-jlr200 · Cited by 119
Self-citationBradford, B. J., Mamedova, L. K., Minton, J. E., Drouillard, J. S., & Johnson, B. J. (2009) · Journal of Nutrition · doi:10.3945/jn.109.108233 · Cited by 117
Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Nagaya, T., Tanaka, N., Suzuki, T., Sano, K., Horiuchi, A., Komatsu, M., Nakajima, T., Nishizawa, T., Joshita, S., Umemura, T., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.033 · Cited by 117
Steroid receptor coactivators: servants and masters for control of systems metabolism
Stashi, E., York, B., & O’Malley, B. W. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.05.004 · Cited by 108
Thyroid axis function and dysfunction in critical illness
Mebis, L., & Van den Berghe, G. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.03.002 · Cited by 99
Bionaz, M., Thering, B. J., & Loor, J. J. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511002777 · Cited by 100
Reddy, R. C., Narala, V. R., Keshamouni, V. G., Milam, J. E., Newstead, M. W., & Standiford, T. J. (2008) · Blood · doi:10.1182/blood-2007-12-128967 · Cited by 102
Flowers, M. T., Keller, M. P., Choi, Y., Hong, L., Kendziorski, C. M., Ntambi, J. M., & Attie, A. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00139.2007 · Cited by 95
Zingarelli, B., Piraino, G., Hake, P. W., O’Connor, M. P., Denenberg, A. G., Fan, H., & Cook, J. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091010 · Cited by 86
PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections
Bassaganya-Riera, J., Song, R., Roberts, P. C., & Hontecillas, R. (2010) · Viral Immunology · doi:10.1089/vim.2010.0016 · Cited by 83
Mandard, S., & Patsouris, D. (2013) · PPAR Research · doi:10.1155/2013/613864 · Cited by 84
Some new aspects of nutrition, health conditions and fertility of intensively reared dairy cows
Bertoni, G., Trevisi, E., & Lombardelli, R. (2009) · Italian Journal of Animal Science · doi:10.4081/ijas.2009.491 · Cited by 82
Mogilenko, D. A., Dizhe, E. B., Shavva, V. S., Lapikov, I. A., Orlov, S., & Ap, P. (2009) · Biochemistry · doi:10.1021/bi9015742 · Cited by 79
Ducheix, S., Montagner, A., Théodorou, V., Ferrier, L., & Guillou, H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.016 · Cited by 79
Pathogenesis of alcoholic liver disease: the role of nuclear receptors
Gyamfi, M. A., & Wan, Y. Y. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009249 · Cited by 76
Chen, Y., Pat, B., Gladden, J. D., Zheng, J., Powell, P. C., Wei, C., Cui, X., Husain, A., & Dell’Italia, L. J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01104.2010 · Cited by 71
Crosstalk between TNF and glucocorticoid receptor signaling pathways
Bogaert, T. V., Bosscher, K. D., & Libert, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.04.003 · Cited by 71
Pedersen, G., & Brynskov, J. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.749 · Cited by 67
Marcil, V., Seidman, E. G., Sinnett, D., Boudreau, F., Gendron, F., Beaulieu, J., Ménard, D., Précourt, L., Amre, D. K., & Levy, E. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155358 · Cited by 64
Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia
Maitra, U., Chang, S., Singh, N., & Li, L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.08.023 · Cited by 64
Tumor Necrosis Factor Inhibits Glucocorticoid Receptor Function in Mice
Bogaert, T. V., Vandevyver, S., Dejager, L., Hauwermeiren, F. V., Pinheiro, I., Πέττα, Ι., Engblom, D., Kleyman, A., Schütz, G., Tuckermann, J. P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212365 · Cited by 66
The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss
Veum, V. L., Dankel, S. N., Gjerde, J., Nielsen, H. J., Solsvik, M. H., Haugen, C., Christensen, B. J., Hoang, T., Fadnes, D. J., Busch, C., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.240 · Cited by 63
A chronic high-cholesterol diet paradoxically suppresses hepatic CYP7A1 expression in FVB/NJ mice
Henkel, A. S., Anderson, K. A., Dewey, A. M., Kavesh, M. H., & Green, R. M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m012781 · Cited by 63
TNF-α interferes with lipid homeostasis and activates acute and proatherogenic processes
Tacer, K. F., Kuzman, D., Seliškar, M., Pompon, D., & Rozman, D. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00264.2006 · Cited by 62
Gyamfi, M. A., He, L., French, S. W., Damjanov, I., & Wan, Y. Y. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132258 · Cited by 60
Fontaine‐Bisson, B., Wolever, T. M. S., Chiasson, J., RABASA-LHORET, R. P. R., Maheux, P., Josse, R. G., Leiter, L. A., Rodger, N., Ryan, E. A., Connelly, P. W., et al. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.768 · Cited by 60
Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm
Feingold, K. R., Moser, A., Patzek, S. M., Shigenaga, J. K., & Grunfeld, C. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800655-jlr200 · Cited by 59
Self-citationLPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes
Lü, B., Lu, Y., Moser, A. H., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90323.2008 · Cited by 58
Self-citationCisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting
Lancaster, C. S., Hu, C., Franke, R. M., Filipski, K. K., Orwick, S. J., Chen, Z., Zuo, Z., Loos, W. J., & Sparreboom, A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1239 · Cited by 55
Bjørndal, B., Berge, C., Ramsvik, M. S., Svardal, A. M., Bohov, P., Skorve, J., & Berge, R. K. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-143 · Cited by 51
Cheung, K. T., Sze, D., Chan, K. H., & Leung, P. H. M. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.044 · Cited by 48
Dkhil, M. A., Al‐Quraishy, S., Abdel‐Baki, A. S., Ghanjati, F., Araúzo-Bravo, M. J., Delić, D., & Wunderlich, F. T. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.006 · Cited by 46
Haschke, M., Vitins, T., Lude, S., Todesco, L., Novakova, K., Herrmann, R., & Krähenbühl, S. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp456 · Cited by 46
Cruz-Garcia, L., Saera-Vila, A., Navarro, I., Calduch-Giner, J. À., & Pérez‐Sánchez, J. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.029025 · Cited by 45
Sæterstad, S., Østvik, A. E., Røyset, E. S., Bakke, I., Sandvik, A. K., & Granlund, A. V. B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265189 · Cited by 44
Saadane, A., Mast, N., Trichonas, G., Chakraborty, D., Hammer, S. S., Busik, J. V., Grant, M. B., & Pikuleva, I. A. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.10.013 · Cited by 42
Liver-inherent immune system: its role in blood-stage malaria
Wunderlich, F. T., Al‐Quraishy, S., & Dkhil, M. A. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00559 · Cited by 41
Keller, R., Klein, M., Thomas, M., Dräger, A., Metzger, U., Templin, M. F., Joos, T. O., Thasler, W. E., Zell, A., & Zanger, U. M. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004431 · Cited by 42
Rat Urinary Bladder Carcinogenesis by Dual‐Acting PPARα + γ Agonists
Oleksiewicz, M. B., Southgate, J., Iversen, L., & Egerod, F. L. (2008) · PPAR Research · doi:10.1155/2008/103167 · Cited by 41
Analysis of Common and Specific Mechanisms of Liver Function Affected by Nitrotoluene Compounds
Deng, Y., Meyer, S. A., Guan, X., Escalon, B. L., Ai, J., Wilbanks, M. S., Welti, R., García‐Reyero, N., & Perkins, E. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014662 · Cited by 40
Peroxisome Proliferator‐Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease
Mello, T., Polvani, S., & Galli, A. (2009) · PPAR Research · doi:10.1155/2009/748174 · Cited by 38
Herrema, H., Derks, T. G. J., van Dijk, T. H., Bloks, V. W., Gerding, A., Havinga, R., Tietge, U. J. F., Müller, M. M., Smit, P. G. A., Kuipers, F., et al. (2008) · Hepatology · doi:10.1002/hep.22284 · Cited by 38
Arzuaga, X., Reiterer, G., Májková, Z., Kilgore, M., Toborek, M., & Hennig, B. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-9005-8 · Cited by 31
Osto, M., Zini, E., Franchini, M., Wolfrum, C., Guscetti, F., Häfner, M., Ackermann, M., Reusch, C. E., & Lutz, T. A. (2011) · Endocrinology · doi:10.1210/en.2010-0999 · Cited by 35
Liver X Receptors, Atherosclerosis and Inflammation
Michael, D. R., Ashlin, T. G., Buckley, M. L., & Ramji, D. P. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0239-y · Cited by 35
Arzuaga, X., Na, R., Stromberg, A. J., Black, E. P., Arsenescu, V., Cassis, L. A., Májková, Z., Toborek, M. J., & Hennig, B. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.05.008 · Cited by 35
Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2
Secor McVoy, J. R., Oughli, H. A., & Oh, U. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0247-2 · Cited by 34
Sanz, M., Albertos, F., Otero, E., Juez, M., Morcillo, E. J., & Piqueras, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102942 · Cited by 33
Blunder, S., Krimbacher, T., Moosbrugger‐Martinz, V., Gruber, R. W., Schmuth, M., & Dubrac, S. (2021) · Experimental Dermatology · doi:10.1111/exd.14323 · Cited by 32
HDL and innate immunity: a tale of two apolipoproteins
Grünfeld, C., & Feingold, K. R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.e800011-jlr200 · Cited by 32
Self-citationIvan, F. X., Rajapakse, J. C., Welsch, R. E., Rozen, S., Narasaraju, T., Xiong, G. M., Engelward, B. P., & Chow, V. T. K. (2011) · Functional & Integrative Genomics · doi:10.1007/s10142-011-0247-y · Cited by 31
Szalowska, E., Stoopen, G. M., Groot, M., Hendriksen, P. J. M., & Peijnenburg, A. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-39 · Cited by 31
Ryan, K. M., Patterson, I., & McLoughlin, D. M. (2018) · Psychological Medicine · doi:10.1017/s0033291718002556 · Cited by 30
Li, P., Wang, Y., Luo, J. F., Zeng, Q., Wang, M., Bai, M., Zhou, H., Wang, J., & Jiang, H. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114115 · Cited by 30
Lado-Abeal, J., Romero, A., Castro-Piedras, I., Rodriguez-Perez, A., & Alvarez-Escudero, J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0376 · Cited by 29
The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis
Wang, H., Wang, L., Li, Y., Luo, S., Ye, J., Lu, Z., Li, X., & Lu, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111778 · Cited by 29
Bjørndal, B., Vik, R., Brattelid, T., Vigerust, N. F., Burri, L., Bohov, P., Nygard, O. K., Skorve, J., & Berge, R. K. (2012) · Metabolism · doi:10.1016/j.metabol.2012.03.012 · Cited by 29
Deng, X., Liguori, M. J., Sparkenbaugh, E., Waring, J. F., Blomme, E. A. G., Ganey, P. E., & Roth, R. A. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.140335 · Cited by 29
Foxa2-dependent hepatic gene regulatory networks depend on physiological state
Bochkis, I. M., Schug, J., Rubins, N. E., Chopra, A. R., O’Malley, B. W., & Kaestner, K. H. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.90376.2008 · Cited by 28
Solan, P. D., Piraino, G., Hake, P. W., Denenberg, A. G., O’Connor, M. P., Lentsch, A. B., & Zingarelli, B. (2010) · Shock · doi:10.1097/shk.0b013e3181f7d742 · Cited by 29
Qu, Q., Qu, J., Guo, Y. G., Zhou, B., & Zhou, H. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000125 · Cited by 28
Álba, G., Reyes-Quiróz, M. E., Santa‐María, C., Ramírez, R., Geniz, I., Jiménez, J., Martín‐Nieto, J., Pintado, E., & Sobrino, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042195 · Cited by 27
Suganuma, I., Mori, T., Ito, F., Tanaka, Y., Sasaki, A., Matsuo, S., Kusuki, I., & Kitawaki, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2525 · Cited by 27
Li, N., Salter, R., & Ramji, D. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22976 · Cited by 29
The bidirectional interaction of COVID-19 infections and lipoproteins
Feingold, K. R. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101751 · Cited by 26
Self-citationYang, X., Wu, F., Li, L., Lynch, E. C., Xie, L., Zhao, Y. Q., Fang, K., Li, J., Luo, J., Xu, L., et al. (2020) · Phytotherapy Research · doi:10.1002/ptr.6800 · Cited by 26
Tzika (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000244 · Cited by 28
Lim, W. S., Ng, D. L., Kor, S. B., Wong, H. K., Muhammad, T. S. T., Choo, Q.-C., & Chew, C.-H. (2012) · Cytokine · doi:10.1016/j.cyto.2012.10.007 · Cited by 25
Gehrke, N., Hofmann, L. J., Straub, B. K., Rühle, F., Waisman, A., Galle, P. R., & Schattenberg, J. M. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1048 · Cited by 23
Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis
Mulder, J. (2009) · Frontiers in bioscience · doi:10.2741/3400 · Cited by 24
Akbar, H., Batistel, F., Drackley, J. K., & Loor, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139963 · Cited by 23
Alteration of Canalicular Transporters in a Mouse Model of Total Parenteral Nutrition
Tazuke, Y., & Teitelbaum, D. H. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181852201 · Cited by 23
Kosters, A., White, D., Sun, H., Thevananther, S., & Karpen, S. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.029 · Cited by 22
Aguirre, R. S., & Karpen, S. J. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085555 · Cited by 22
Luo, M., Yeruva, S., Liu, Y., Chodisetti, G., Riederer, B., Menon, M., Tachibana, K., Doi, T., & Seidler, U. E. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00061 · Cited by 22
Yuhas, Y., Berent, E., Cohen, R., & Ashkenazi, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00961-08 · Cited by 22
Modulation of Cellular Redox Parameters for Improving Therapeutic Responses in Multiple Myeloma
Allegra, A., Petrarca, C., Gioacchino, M. D., Casciaro, M., Musolino, C., & Gangemi, S. (2022) · Antioxidants · doi:10.3390/antiox11030455 · Cited by 21
Fontaine‐Bisson, B., & El‐Sohemy, A. (2008) · Lifestyle Genomics · doi:10.1159/000149825 · Cited by 21
Mozzicafreddo, M., Cuccioloni, M., Bonfili, L., Cecarini, V., Palermo, F. A., Cocci, P., Mosconi, G., Capone, A., Ricci, I., Eleuteri, A. M., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.04.011 · Cited by 27
Kupffer cells modulate hepatic fatty acid oxidation during infection with PR8 influenza
Tarasenko, T. N., Singh, L. N., Chatterji-Len, M., Zerfas, P. M., Cusmano‐Ozog, K. P., & McGuire, P. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.021 · Cited by 23
Kasimanickam, R. K., Kasimanickam, V. R., & Grende, K. (2019) · Theriogenology · doi:10.1016/j.theriogenology.2019.10.036 · Cited by 20
Guo, Y., Liu, B., Geng, Y., Chen, K., Li, J., Yin, X., & Zhang, S. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113783 · Cited by 19
Fan, A., Wang, Q., Yuan, Y., Cheng, J.-L., Chen, L., Guo, X., Li, Q., Chen, B., Huang, X., & Huang, Q. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00102.2015 · Cited by 19
حاتمی, م., Saidijam, M., Yadegarzari, R., Borzuei, S., Soltanian, A. R., Arian, M. S., & Goodarzi, M. T. (2016) · Chonnam Medical Journal · doi:10.4068/cmj.2016.52.3.201 · Cited by 19
Erkens, T., Vandesompele, J., Zeveren, A. V., & Peelman, L. J. (2009) · Journal of Applied Genetics · doi:10.1007/bf03195694 · Cited by 18
Shavva, V. S., Mogilenko, D. A., Bogomolova, A. M., Nikitin, A. A., Dizhe, E. B., Efremov, A. M., Oleinikova, G. N., Ap, P., & Orlov, S. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25498 · Cited by 18
Inflammatory reactions and drug response: importance of cytochrome P450 and membrane transporters
Dumais, G., Iovu, M. O., & du Souich, P. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.5.627 · Cited by 18
Metadata
- Authors
- Kim, M. S., Sweeney, T. R., Shigenaga, J. K., Chui, L. G., Moser, A., Grunfeld, C., & Feingold, K. R.
- Affiliations
- University of California, San Francisco (US)
- San Francisco VA Medical Center (US)
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 56
- Issue
- 2
- Pages
- 267-279
- ISSN
- 0026-0495 (ISSN-L)
- PMC
- PMC2700944
- OpenAlex
- W1966030580
- Cited by
- 168
- References
- 44
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 5 · 2022: 10 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 9 · 2015: 8 · 2014: 7 · 2013: 7 · 2012: 11
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD029706, R01 HD29706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- TNF-α, interleukin-1, acute phase response, nuclear receptors, retinoid X receptor alpha, PPARα, PPARγ, liver X receptor alpha, PGC-1α, PGC-1β, SRC-1, transcriptional coactivator, hepatic lipid metabolism, hepatocytes, SREBP, cytokine-induced gene expression
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Liver X Receptors, Acute-Phase Reaction, Animals, Cell Nucleus, DNA-Binding Proteins, Interleukin-1, Liver, Mice, Inbred C57BL, Receptors, Cell Surface, RNA, Messenger, Transcription Factors, Transfection, Blotting, Northern, Blotting, Western, Trans-Activators, Receptors, Cytoplasmic and Nuclear, Hepatocytes, Retinoid X Receptor alpha, PPAR alpha, PPAR gamma, Tumor Necrosis Factors, Mice, Histone Acetyltransferases, Nuclear Receptor Coactivator 1, Orphan Nuclear Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review